PH

Philippines

1339 clinical trials

Find Trials

Clinical Trials (1339)

Showing 20 of 1,339 trialsScroll for more
NCT06841354Phase 32 sites

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Recruiting
NCT06077760Phase 33 sites

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

Recruiting
NCT06467357Phase 34 sites

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

Recruiting
NCT03486873Phase 33 sites

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Recruiting
NCT06667700Phase 34 sites

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

Recruiting
NCT04976322Phase 32 sites

A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus

Enrolling By Invitation
NCT06966700Phase 32 sites

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Recruiting
NCT05030428Phase 34 sites

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

Active Not Recruiting
NCT06800248Phase 31 site

Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections

Not Yet Recruiting
NCT05352919Phase 38 sites

An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

Enrolling By Invitation
NCT05739383Phase 35 sites

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Active Not Recruiting
NCT05211895Phase 37 sites

A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC

Recruiting
NCT06872892Phase 35 sites

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

Recruiting
NCT07497087Phase 33 sites

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

Not Yet Recruiting
NCT07064473Phase 310 sites

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Recruiting
NCT07220083Phase 31 site

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

Recruiting
NCT04961996Phase 310 sites

A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)

Active Not Recruiting
NCT06926660Phase 23 sites

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease

Active Not Recruiting
NCT06935357Phase 31 site

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

Recruiting
NCT06981078Phase 29 sites

A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD

Active Not Recruiting